Islatravir (ISL) is an antiretroviral drug used, in fixed-dose combination with doravirine, as a switch regimen for the treatment of HIV-1 infection in adults. The combination, marketed as Idvynso, was approved by the FDA in April 2026.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.